Pharmacokinetics of mycophenolic acid in kidney transplant recipients treated with a low dose (1 gram/day) of mycophenolate mofetil. 2003

Wichian Julasareekul, and Somchai Eiam-Ong, and Ornanong Bejraputra, and Tada Seublinvong
Nephrology Unit, Medicine, Queen Sawangwatana Memorial Hospital, Chon Buri 20110, Thailand.

Pharmacokinetic studies of mycophenolic acid (MPA) were performed in 16 stable Thai kidney transplant recipients treated with 1 g/d of mycophenolate mofetil (MMF). The complete area under the blood concentration-time curve (AUC) of MPA was determined using the linear trapezoidal rule from 8 concentrations at, 0, 1, 2, 3, 4, 6, 8, and 12 h after MMF administration. The mean values of AUC(0-12) were 37.54 + 0.80 microg x h/ml. MPA concentrations at 8 h after dosing, not the trough or maximum levels, showed the best correlation with AUC(0-12) (r2 = 0.72). The equation model of abbreviated AUC of MPA, derived by multiple linear regression analysis, that had the highest correlation (r2) and lowest absolute prediction error (APE) was: AUC = 0.6 C1 + 1.9 C3 + 8.68 C8 + 4.65 (r2 = 0.92, APE = 2.05 +/- 0.32%). The best abbreviated AUC equations obtained by linear trapezoidal rule were: AUC = 4.5 C0 + C1 + 1.5 C2 + 5 C4 (r2 = 0.78, APE = 5.78 +/- 1.14%) and AUC = 5 C0 + C1 + C2 + 5 C3 (r2 = 0.76, APE = 6.21 +/- 1.46%).

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009173 Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. Cellcept,Mycophenolate Mofetil,Mycophenolate Mofetil Hydrochloride,Mycophenolate Sodium,Mycophenolic Acid Morpholinoethyl Ester,Myfortic,RS 61443,RS-61443,Sodium Mycophenolate,Mofetil Hydrochloride, Mycophenolate,Mofetil, Mycophenolate,Mycophenolate, Sodium,RS61443
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal
D019540 Area Under Curve A statistical means of summarizing information from a series of measurements on one individual. It is frequently used in clinical pharmacology where the AUC from serum levels can be interpreted as the total uptake of whatever has been administered. As a plot of the concentration of a drug against time, after a single dose of medicine, producing a standard shape curve, it is a means of comparing the bioavailability of the same drug made by different companies. (From Winslade, Dictionary of Clinical Research, 1992) AUC,Area Under Curves,Curve, Area Under,Curves, Area Under,Under Curve, Area,Under Curves, Area

Related Publications

Wichian Julasareekul, and Somchai Eiam-Ong, and Ornanong Bejraputra, and Tada Seublinvong
January 2000, Transplant international : official journal of the European Society for Organ Transplantation,
Wichian Julasareekul, and Somchai Eiam-Ong, and Ornanong Bejraputra, and Tada Seublinvong
September 2004, Transplantation proceedings,
Wichian Julasareekul, and Somchai Eiam-Ong, and Ornanong Bejraputra, and Tada Seublinvong
March 2001, Journal of clinical pharmacology,
Wichian Julasareekul, and Somchai Eiam-Ong, and Ornanong Bejraputra, and Tada Seublinvong
January 2008, Clinical pharmacokinetics,
Wichian Julasareekul, and Somchai Eiam-Ong, and Ornanong Bejraputra, and Tada Seublinvong
October 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
Wichian Julasareekul, and Somchai Eiam-Ong, and Ornanong Bejraputra, and Tada Seublinvong
April 2013, Journal of clinical pharmacology,
Wichian Julasareekul, and Somchai Eiam-Ong, and Ornanong Bejraputra, and Tada Seublinvong
September 2004, Transplantation proceedings,
Wichian Julasareekul, and Somchai Eiam-Ong, and Ornanong Bejraputra, and Tada Seublinvong
March 1999, Clinical chemistry,
Wichian Julasareekul, and Somchai Eiam-Ong, and Ornanong Bejraputra, and Tada Seublinvong
February 2006, Transplantation,
Wichian Julasareekul, and Somchai Eiam-Ong, and Ornanong Bejraputra, and Tada Seublinvong
January 2007, Clinical transplantation,
Copied contents to your clipboard!